Is a complete CLGN research report available?

No complete published report is available for CollPlant Biotechnologies Ltd. (CLGN) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

CollPlant Biotechnologies Ltd. (CLGN)

NASDAQ: CLGN · USD

$0.31

+0.00 (+0.8%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-25 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first CLGN analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	6M
Revenue (ttm)	389K
Net income (ttm)	-13.1M
EPS (ttm)	-$1.03
Shares out	18.9M
Volume	7,136.856
Beta	0.65

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 389K
Net income (ttm): -13.1M
EPS (ttm): -$1.03
Market cap: 6M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All CLGN indicators

Market & fundamental data

Available fields

197

Groups with data

Currency

USD

Showing 197 of 197 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001631487
Company name	CollPlant Biotechnologies Ltd.
Country	Israel
Country code	US
Cusip	19516R107
Employees	39
Employees Change	-18%
Employees Change Percent	-31.58
Enterprise value	$4.3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	IL0004960188
Last refreshed	2026-07-25
Market cap	$6M
Market cap category	Nano-Cap
Price	$0.31
Price currency	USD
Rev Per Employee	9,974.36x
Sector	Healthcare
Sector PE	44.8
Sector PE Fwd	23.59
Sic	3842
Symbol	CLGN
Website	https://collplant.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-220.65%
EV Sales Forward	2.87x
EV/EBIT	0.66x
EV/EBITDA	0.58x
EV/Sales	11.16x
FCF yield	-190.28%
P/B ratio	0.93x
P/S ratio	15.3x
PS Forward	3.94x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	1,695.12%
EBITDA Margin	1,920.82%
Gross margin	-147.56%
Gross Profit	$-574,000
Net Income	$-13.1M
Net Income Growth Years	1%
Pretax Margin	-3,376.35%
Profit Per Employee	$-336,769
ROA	-61.34
Roa5y	-25.28
ROCE	97.82
ROE	-152
Roe5y	-52.59
ROIC	-71.08

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-33.24%
Cagr1y	-87.17%
Cagr3y	-63.14%
Cagr5y	-55.34%
EPS Growth Years	1
Revenue Growth	-84.26x
Revenue Growth Q	-96.45x
Revenue Growth Years	1x
Revenue Growth3 Y	-16.41x
Revenue Growth5 Y	-54.54x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.03
Assets	$9.2M
Cash	$4.3M
Current Assets	$5.5M
Current Liabilities	$2.4M
Debt	$2.6M
Debt EBITDA	$0.35
Debt Equity	$0.54
Equity	$4.9M
Liabilities	$4.3M
Long Term Assets	$3.6M
Long Term Liabilities	$1.9M
Net Cash	$1.6M
Net Cash By Market Cap	$27.1
Net Cash Growth	-79.56%
Net Debt EBITDA	$-0.22
Net Debt Equity	$-0.33
Tangible Book Value	$4.8M
Tangible Book Value Per Share	$0.33
WACC	5.43

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.27
Inventory Turnover	1.42
Net Working Capital	$-371,000
Quick ratio	1.84
Working Capital	$3.1M
Working Capital Turnover	$0.06

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-11.54%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-98.24%
1Y total return	-87.15%
200-day SMA	1.06
3Y total return	-95%
50-day SMA	0.37
50-day SMA vs 200-day SMA	50under200
5Y total return	-98.22%
All Time High	27.86
All Time High Change	-98.87%
All Time High Date	2015-08-11
All Time Low	0.27
All Time Low Change	16.12%
All Time Low Date	2026-04-15
ATR	0.04
Beta	0.65
Beta1y	-0.59
Beta2y	0.01
Ch YTD	-77.51
High	0.33
High52	3.23
High52 Date	2025-08-12
High52ch	-90.26%
Low	0.31
Low52	0.27
Low52 Date	2026-04-15
Low52ch	16.12%
Ma50ch	-14.69%
Price vs 200-day SMA	-70.39%
RSI	40.39
RSI Monthly	33.72
RSI Weekly	29.22
Sharpe ratio	-1.22x
Sortino ratio	-1.53
Total Return	-11.54%
Tr YTD	-77.51
Tr1m	-10.57%
Tr1w	-6.03%
Tr3m	-11.72%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-0.24
Earnings Revenue Estimate	1,465,780x
Earnings Revenue Estimate Growth	718.87x
Operating Income	$-13M
Operating margin	-3,329

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	14,633,461%
Float Percent	77.39%
Shares Insiders	21.71%
Shares Institutions	8.12%
Shares Out	18,908,207
Shares Qo Q	7.52%
Shares Yo Y	11.54%
Short Ratio	0.39
Short Shares	0.32

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-12.1M
Average Volume	32,648.2x
Bv Per Share	0.34
CAPEX	$-25,000
Ch10y	-98.24
Ch1m	-10.57
Ch1w	-6.03
Ch1y	-87.15
Ch3m	-11.72
Ch3y	-95
Ch5y	-98.22
Ch6m	-83.43
Change	0.77%
Change From Open	-2.9
Close	0.31
Days Gap	3.78
Depreciation Amortization	878,000
Dollar Volume	2,246.7
Earnings Date	2026-08-19
Earnings Time	bmo
EBIT	$6.6M
EBITDA	$7.5M
EPS	$-1.03
F Score	1
FCF	$-11.3M
FCF EV Yield	-261.01x
FCF Per Share	$-0.6
Financing CF	4,821,000
Fiscal Year End	December
Founded	2,004
Investing CF	-25,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-29
Last Report Date	2026-03-31
Last Split Date	2016-11-21
Last Split Type	Reverse
Last10k Filing Date	2026-03-26
Ma150	0.71
Ma150ch	-55.41%
Ma20	0.35
Ma20ch	-9.2%
Net CF	-6,473,000
Next Earnings Date	2026-08-19
Open	0.32
Optionable	Yes
Position In Range	23.76
Ppne	3,508,000
Price Date	2026-07-24
Price EBITDA	$0.8
Ptbv Ratio	1.23
Relative Volume	0.22x
Revenue	389,000x
SBC By Revenue	204.88x
Share Based Comp	797,000
Tr6m	-83.43%
Volume	7,136.9
Z Score	-20.43

CollPlant Biotechnologies Ltd. (CLGN)

Coverage state: Market snapshot only — no published research

Generate the first CLGN analysis

Price

Financial snapshot

Fair-value bridge

Latest news · CLGN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CLGN indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on CLGN

Frequently asked questions